naproxen

(redirected from naproxen sodium)
Also found in: Dictionary, Thesaurus, Medical, Wikipedia.
Related to naproxen sodium: Aleve

naproxen

and

naproxen sodium,

potent nonsteroidal anti-inflammatory drugs (NSAID) used to alleviate the minor pain of arthritis, menstruation, headaches, and the like, and to reduce fever. Along with ibuprofenibuprofen
, nonsteroidal anti-inflammatory drug (NSAID) that reduces pain, fever, and inflammation. Along with naproxen and ketoprofen, ibuprofen belongs to the propionic acid class of NSAIDs. It was first made available in 1967.
..... Click the link for more information.
 and ketoprofenketoprofen
, nonsteroidal anti-inflammatory drug (NSAID) with anti-inflammatory, analgesic, and fever-reducing effects, used to relieve the symptoms of headaches, arthritis, and painful menstruation.
..... Click the link for more information.
, they belong to the propionic acid class of NSAIDs. They have been available as prescription drugs for arthritis from 1976. Naproxen sodium was approved at a low dosage as an over-the-counter painkiller in the United States in 1994; it was first marketed under the tradename Aleve. Side effects may include gastrointestinal distress and dizziness, and renal impairment has been reported in some instances with long-term use. The drugs should not be used by those who are allergic to aspirinaspirin,
acetyl derivative of salicylic acid (see salicylate) that is used to lower fever, relieve pain, reduce inflammation, and thin the blood. Common conditions treated with aspirin include headache, muscle and joint pain, and the inflammation caused by rheumatic fever and
..... Click the link for more information.
.
References in periodicals archive ?
NAPRELAN Tablets are contraindicated in patients with known hypersensitivity to naproxen or naproxen sodium.
Andrx launched its 500 mg Naproxen Sodium ER tablets in September 2002.
Findings from these pivotal studies demonstrated that Treximet provided more patients migraine pain relief at two and four hours compared to sumatriptan 85 mg, naproxen sodium 500 mg or placebo alone.
This research explored the effect of OTC doses of naproxen sodium (220 mg tid) or acetaminophen (1,000 mg qid) on the antiplatelet effect when administered together with low-dose aspirin therapy (81mg).
SafeBridge") headquartered in Mountain View, California announced today that its industrial hygiene analytical laboratory has recently validated an industrial hygiene air sampling and analytical method with improved analytical sensitivity for measurement of naproxen sodium on filters.
These data, confirming that the OTC dose of naproxen sodium did not interfere with daily doses of 81 mg aspirin, add to the significant body of evidence that support the cardiovascular safety of naproxen," said study author Marc C.
Victory's lead product is NAPRELAN([R]), which is the only branded, once-daily sustained release formulation of naproxen sodium, a non-steroidal anti-inflammatory drug (NSAID).
The active ingredients in ALEVE-D, pseudoephedrine (PSE) and naproxen sodium combine to provide 12 hours of relief from symptoms including sinus pressure, headache, and nasal and sinus congestion.
The FDA has requested that POZEN further address the Agency's concern, prior to approval, about the potential implications from one preclinical in vitro chromosomal aberration study (one of four standard genotoxicity assays) in which genotoxicity was seen for the combination of naproxen sodium and sumatriptan, but not with either component alone.
NAPRELAN is the only once-a-day, formulation of naproxen sodium.
Trexima, the proposed brand name for a single tablet containing sumatriptan 85 mg formulated with RT Technology(TM) and naproxen sodium 500 mg, is currently under review by the FDA for the acute treatment of migraines in adults.
POZEN has development and commercialization alliances with GlaxoSmithKline for the proposed product candidate Trexima[TM] combining sumatriptan, formulated with RT Technology[TM], and naproxen sodium in a single tablet for the acute treatment of migraine, which is currently under review by the United States Food and Drug Administration, and with AstraZeneca for the proprietary fixed dose combination of the proton pump inhibitor esomeprazole magnesium with naproxen in a single tablet for conditions such as osteoarthritis and rheumatoid arthritis in patients who are at risk for developing NSAID-associated gastric ulcers.